 BURNABY, British Columbia, Nov. 09, 2022 GLOBE NEWSWIRE -- Xenon Pharmaceuticals Inc. Nasdaq:XENE, a neurology-focused biopharmaceutical company, today announced that Ian Mortimer, Xenons President and Chief Executive Officer, along with Sherry Aulin, Xenons Chief Financial Officer, will host fireside chat presentations and participate in one-on-one meetings at the following investor conferences: 